Embolex and Lantus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Embolex (dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride) and Lantus (insulin glargine recombinant). Common drug interactions include stevens-johnson syndrome among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Embolex and Lantus. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Embolex?

Embolex has active ingredients of dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride. eHealthMe is studying from 1,161 Embolex users. Check the latest studies of Embolex.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.



On Jul, 10, 2026

21 people who take Embolex and Lantus together, and have interactions are studied.

Embolex and Lantus drug interactions.

What are the common drug interactions of Embolex and Lantus, by gender? *:

female:

  1. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  2. Pyrexia (fever)
  3. Anaemia (lack of blood)
  4. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  5. Duodenal stenosis (block of the first part of the small intestine)
  6. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
  7. Erythema (redness of the skin)
  8. Gait disturbance
  9. Haemangioma of skin (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs)
  10. Ketoacidosis (high concentrations of ketone bodies in blood)

male:

  1. Pyrexia (fever)
  2. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  3. Peripheral arterial occlusive disease (reproducible ischemic muscle pain)
  4. Pleural effusion (water on the lungs)
  5. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
  6. Fatigue (feeling of tiredness)
  7. Chills (felling of cold)
  8. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  9. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  10. Completed suicide (act of taking one's own life)

What are the common drug interactions of Embolex and Lantus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Ketoacidosis (high concentrations of ketone bodies in blood)
  2. Somnolence (a state of near-sleep, a strong desire for sleep)
  3. Stupor (lack of critical cognitive function and level of consciousness)

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Pyrexia (fever)
  2. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  3. General physical health deterioration (weak health status)
  4. Hepatitis (inflammation of the liver)
  5. Inguinal hernia (hernia in which a loop of intestine enters the inguinal canal; the most common type of hernia in males)
  6. Lower limb fracture
  7. Necrosis (the death of body tissue)
  8. Nikolsky's sign
  9. Ocular hyperaemia (an abnormally large amount of blood in eye)
  10. Peripheral arterial occlusive disease (reproducible ischemic muscle pain)

What are the existing conditions these people have? *

  1. Hyperglycemia (high blood sugar): 9 people, 42.86%
  2. Diarrhea: 7 people, 33.33%
  3. High Blood Pressure: 5 people, 23.81%
  4. Type 2 Diabetes: 5 people, 23.81%
  5. Fever: 5 people, 23.81%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 23.81%
  7. Indigestion: 4 people, 19.05%
  8. Nausea (feeling of having an urge to vomit): 4 people, 19.05%
  9. Nasopharyngitis (inflammation of the nasopharynx): 4 people, 19.05%
  10. Muscle Spasms (muscle contraction): 4 people, 19.05%

* Approximation only. Some reports may have incomplete information.

Do you take Embolex and Lantus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Embolex and Lantus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Embolex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lantus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Embolex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lantus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride and insulin glargine recombinant (the active ingredients of Embolex and Lantus, respectively), and Embolex and Lantus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: